Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (nemo) oligomerization. - Wikidata - wikimedia - TriplyDB

Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (nemo) oligomerization.

Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (nemo) oligomerization.

http://www.wikidata.org/entity/Q40507772

about

Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins The IkappaB kinase complex: master regulator of NF-kappaB signaling Super-resolution microscopy reveals a preformed NEMO lattice structure that is collapsed in incontinentia pigmenti Phenotype-based identification of host genes required for replication of African swine fever virus Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.Cell penetrating peptide inhibitors of nuclear factor-kappa B.Thrombopoietin promotes NHEJ DNA repair in hematopoietic stem cells through specific activation of Erk and NF-κB pathways and their target, IEX-1 IKK biology.Evidence that the kinase-truncated c-Src regulates NF-κB signaling by targeting NEMO.Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis Inhibition of Canonical NF-κB Signaling by a Small Molecule Targeting NEMO-Ubiquitin Interaction Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway.Cell-penetrating TIR BB loop decoy peptides a novel class of TLR signaling inhibitors and a tool to study topology of TIR-TIR interactions.Therapeutic peptides for cancer therapy. Part I - peptide inhibitors of signal transduction cascades.Inhibitory kappa B Kinases as targets for pharmacological regulation.Phosphorylation of serine 68 in the IkappaB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappaB activity.Heptad repeats regulate protein phosphatase 2a recruitment to I-kappaB kinase gamma/NF-kappaB essential modulator and are targeted by human T-lymphotropic virus type 1 tax.Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-kappaB essential modulator binding domain peptides.Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia.Dimerization of the I kappa B kinase-binding domain of NEMO is required for tumor necrosis factor alpha-induced NF-kappa B activity.High-affinity interaction between IKKbeta and NEMO.Patented inhibitors (2002 - 2005) of the transcription factor NF-kappaB.Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity.

P2860

Q24307510-BC19DF64-181B-472D-AB35-899FBAB11A87 Q24313366-8AFD00F2-15EB-40A8-B1B1-92223A6DF699 Q27330416-E0EE21C7-B496-4823-A48F-7D0B68362A8C Q33254115-6540CC5C-B5A0-4C86-8368-D6B960F3C404 Q33296431-46E8A61E-CBC7-4F77-BF5B-205CADF8E644 Q34289086-9B401D99-DF5D-4D84-8AC2-62DE752CDA84 Q35743835-151B0888-9F75-4549-ADCE-FD28B4D0125F Q35848596-F5830D45-E94D-4671-BB46-03F385883AA5 Q35860261-766AF266-88BA-45C9-B4E9-7FFD246CD6D7 Q35860271-030F8C38-8878-4819-B56A-BA015C5EBC6C Q35887748-3680EBA5-19D8-456E-878D-E08C4C04405B Q36705250-85CA0FF6-7BFE-435B-9BD8-26AC564AF6DE Q36897400-7A7E5791-0B67-48A1-AE44-9A6734408DF9 Q37564522-A258E781-488C-441F-A5C8-7F40C30F562A Q37907354-4548D5BD-0C3B-47BE-92D9-C43477A9572C Q40058260-9F63193E-5608-4B99-91AD-8F73DAA4AA94 Q40168522-3180D540-C56F-4924-AA1E-FC791450EFD2 Q40186974-B94494D0-BAF2-4326-BDE5-BB4220921B29 Q40219923-004B55BC-4297-41AE-ABD4-59AEA58C3187 Q41077731-8589E38E-537A-4D37-A13E-062276C600E0 Q41585188-34C244C2-F0C7-4D0F-A47B-D75F89746B5D Q45856870-92DE9DC8-DDA5-4060-BC4D-12C5A17E7D5F Q52538370-987425BC-61CF-4E4A-B421-DE88E778D235

P2860

Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (nemo) oligomerization.

http://www.wikidata.org/entity/Q40507772

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Inhibition of NF-kappa B activ ...... ulator (nemo) oligomerization.

@en

type

label

Inhibition of NF-kappa B activ ...... ulator (nemo) oligomerization.

@en

prefLabel

Inhibition of NF-kappa B activ ...... ulator (nemo) oligomerization.

@en

P1433

Q40507772-189B91AA-464D-4DB3-B5C1-43F2466C9988

P1476

Q40507772-A6F8D081-99D7-4404-9EF8-4535007E25EF

P2093

Q40507772-0923F865-FE3C-4CCB-A4D9-FDA42CC3554B

Q40507772-845AE758-8B63-4296-843B-D4F22638B3F9

Q40507772-A3C2CAFA-F5D1-4774-BBF5-25DF9E908D5D

Q40507772-AB01449C-0DCA-41EF-B5AE-F0D6C7E4322B

Q40507772-C9D7295C-6741-485B-A793-BF8259BFDD14

Q40507772-D7E25F6C-DEBE-483B-A6EA-A1E63052D73A

Q40507772-DFC63A74-2855-4295-B4FD-0E96AF28EA55

Q40507772-EB04C4C4-EA18-494F-852F-D1ABCF9E1CF0

P2860

Q40507772-0BECF3FD-02B4-4432-BD7E-309D2B9F243E

Q40507772-0C6321D3-25B0-40D3-A272-3B2F021A5E1C

Q40507772-1872D454-D957-4817-9B72-3DC9D26268F5

Q40507772-19005546-7BA1-4C36-BEE9-4C69DBC1203E

Q40507772-1B22307C-EB48-414F-BF1E-F2D6504B0D50

Q40507772-1F870232-79A6-4A39-B7B6-D51E038A627D

Q40507772-251FD5D7-85A7-4EDB-972B-1CDEFFB920F3

Q40507772-2AF74936-0196-48AE-80AD-B34A19A4A8C4

Q40507772-2BAC5124-2F25-45E4-8A49-A4E00EE367C2

Q40507772-2EEA1B72-68F0-4CBB-BC2F-22810901CF7A

P304

Q40507772-F47D24FD-54B8-404B-9427-CE24B5933929

P31

Q40507772-0E06191D-9403-47D9-80F4-F314DDCCA514

P356

Q40507772-2C3C3285-60F6-4446-8B90-CA8033436363

P407

Q40507772-897996F2-C726-4189-A9D1-6B67B77610B4

P433

Q40507772-B11F5F6B-2E0F-456B-AFBB-96D505F70CDB

P478

Q40507772-9DE2AB24-BC7F-4968-9928-24C4A2C44E90

P577

Q40507772-631AD872-F037-4D76-973C-7B47E78189AF

P698

Q40507772-BCAFC6C3-62B8-4008-9524-8D11F26A75D5

P921

Q40507772-B9D23481-4DBA-4A88-84B0-63F020AD75EA

P356

P1433

Journal of Biological Chemistry

P1476

Inhibition of NF-kappa B activ ...... ulator (nemo) oligomerization.

@en

P2093

Alain Israël

http://www.w3.org/2001/XMLSchema#string

Fabrice Agou

http://www.w3.org/2001/XMLSchema#string

François Traincard

http://www.w3.org/2001/XMLSchema#string

Françoise Baleux

http://www.w3.org/2001/XMLSchema#string

Gilles Courtois

http://www.w3.org/2001/XMLSchema#string

Jeanne Chiaravalli

http://www.w3.org/2001/XMLSchema#string

Michel Véron

http://www.w3.org/2001/XMLSchema#string

Yves-Marie Coïc

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

vCLAP, a caspase-recruitment domain-containing protein of equine Herpesvirus-2, persistently activates the Ikappa B kinases through oligomerization of IKKgamma

The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis

Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes

IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex

A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO)

Classification of human B-ZIP proteins based on dimerization properties

X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways

P304

54248-54257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M406423200

http://www.w3.org/2001/XMLSchema#string

P407

P433

52

http://www.w3.org/2001/XMLSchema#string

P478

279

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15466857

http://www.w3.org/2001/XMLSchema#string

P921